|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/7076 | |||
| A61K 31/519 | |||
| A61P 19/02 |
| (11) | Number of the document | 1959939 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06821594.6 |
| Date of filing the European patent application | 2006-11-29 | |
| (97) | Date of publication of the European application | 2008-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2012-01-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2006/001374 |
| Date | 2006-11-29 |
| (87) | Number | WO 2007/063538 |
| Date | 2007-06-07 |
| (30) | Number | Date | Country code |
| 740631 P | 2005-11-30 | US |
| (72) |
FISHMAN, Pnina, IL
|
| (73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street P.O. Box 7537, Petach Tikva 49170,
IL
|
| (54) | USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT |
| USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT |